Artykuły w czasopismach na temat „Alternative therapeutics”
Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych
Sprawdź 50 najlepszych artykułów w czasopismach naukowych na temat „Alternative therapeutics”.
Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.
Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.
Przeglądaj artykuły w czasopismach z różnych dziedzin i twórz odpowiednie bibliografie.
Rodrigues, Célia F., Maria E. Rodrigues, and Mariana C. R. Henriques. "Promising Alternative Therapeutics for Oral Candidiasis." Current Medicinal Chemistry 26, no. 14 (2019): 2515–28. http://dx.doi.org/10.2174/0929867325666180601102333.
Pełny tekst źródłaOrtiz, Mariola Vazquez. "Alternative Medicine: Incorporation into Therapeutics Topics." American Journal of Pharmaceutical Education 62, no. 2 (1998): 208–12. http://dx.doi.org/10.1016/s0002-9459(24)01980-6.
Pełny tekst źródłaKole, Ryszard, Marla Vacek, and Tiffany Williams. "Modification of Alternative Splicing by Antisense Therapeutics." Oligonucleotides 14, no. 1 (2004): 65–74. http://dx.doi.org/10.1089/154545704322988067.
Pełny tekst źródłaOvcharenko, Dmitriy, Dmitry Mukhin, and Galina Ovcharenko. "Alternative Cancer Therapeutics: Unpatentable Compounds and Their Potential in Oncology." Pharmaceutics 16, no. 9 (2024): 1237. http://dx.doi.org/10.3390/pharmaceutics16091237.
Pełny tekst źródłaKroll, D. "Cannabinoids as Therapeutics." Focus on Alternative and Complementary Therapies 11, no. 3 (2010): 257. http://dx.doi.org/10.1111/j.2042-7166.2006.tb04701.x.
Pełny tekst źródłaSá, Sara, Ruben Fernandes, Álvaro Gestoso, et al. "Cutibacterium acnes Dysbiosis: Alternative Therapeutics for Clinical Application." Applied Sciences 13, no. 21 (2023): 12086. http://dx.doi.org/10.3390/app132112086.
Pełny tekst źródłaCollier, Joe. "Zanamivir: an alternative translation." Philosophical Transactions of the Royal Society of London. Series B: Biological Sciences 356, no. 1416 (2001): 1945–46. http://dx.doi.org/10.1098/rstb.2001.1039.
Pełny tekst źródłaRajashekaraiah, Vani, and Anusha Berikai Ananthakrishna. "Drug-induced thrombocytopenia – etiology and alternative therapeutic approaches." European Journal of Clinical and Experimental Medicine 21, no. 3 (2023): 617–26. http://dx.doi.org/10.15584/ejcem.2023.3.15.
Pełny tekst źródłaWuellner, Ulrich, and Dragan Grabulovski. "Alternative Scaffolds as Therapeutics in Cancer and Other Diseases." Forum on Immunopathological Diseases and Therapeutics 5, no. 1-2 (2014): 101–14. http://dx.doi.org/10.1615/forumimmundisther.2015014027.
Pełny tekst źródłaOltean, Sebastian. "Modulators of alternative splicing as novel therapeutics in cancer." World Journal of Clinical Oncology 6, no. 5 (2015): 92. http://dx.doi.org/10.5306/wjco.v6.i5.92.
Pełny tekst źródłaEngel, Linda W., and Stephen E. Straus. "Development of therapeutics: opportunities within complementary and alternative medicine." Nature Reviews Drug Discovery 1, no. 3 (2002): 229–37. http://dx.doi.org/10.1038/nrd750.
Pełny tekst źródłaImaga, Ngozi Awa. "Phytomedicines and Nutraceuticals: Alternative Therapeutics for Sickle Cell Anemia." Scientific World Journal 2013 (2013): 1–12. http://dx.doi.org/10.1155/2013/269659.
Pełny tekst źródłaYang, Quan, Jinyao Zhao, Wenjing Zhang, Dan Chen, and Yang Wang. "Aberrant alternative splicing in breast cancer." Journal of Molecular Cell Biology 11, no. 10 (2019): 920–29. http://dx.doi.org/10.1093/jmcb/mjz033.
Pełny tekst źródłaLuo, Jiaoyang, Dan Yan, Meihua Yang, Xiaoping Dong, and Xiaohe Xiao. "Multicomponent Therapeutics of Berberine Alkaloids." Evidence-Based Complementary and Alternative Medicine 2013 (2013): 1–10. http://dx.doi.org/10.1155/2013/545898.
Pełny tekst źródłaMcKay, Tina B., Rachael N. Parker, Morgan J. Hawker, Meghan McGill, and David L. Kaplan. "Silk-Based Therapeutics Targeting Pseudomonas aeruginosa." Journal of Functional Biomaterials 10, no. 3 (2019): 41. http://dx.doi.org/10.3390/jfb10030041.
Pełny tekst źródłaKemper, Kathi J. "Separation or Synthesis: A Holistic Approach to Therapeutics." Pediatrics In Review 17, no. 8 (1996): 279–83. http://dx.doi.org/10.1542/pir.17.8.279.
Pełny tekst źródłaRivera-Espinosa, Liliana, Esaú Floriano-Sánchez, José Pedraza-Chaverrí, et al. "Contributions of Microdialysis to New Alternative Therapeutics for Hepatic Encephalopathy." International Journal of Molecular Sciences 14, no. 8 (2013): 16184–206. http://dx.doi.org/10.3390/ijms140816184.
Pełny tekst źródłaLogan, Michael H., and Kaja Finkler. "Spiritualist Healers in Mexico: Successes and Failures of Alternative Therapeutics." Anthropologica 30, no. 1 (1988): 102. http://dx.doi.org/10.2307/25605253.
Pełny tekst źródłaBehar, Ruth, and Kaja Finkler. "Spiritualist Healers in Mexico: Successes and Failures of Alternative Therapeutics." Contemporary Sociology 16, no. 3 (1987): 404. http://dx.doi.org/10.2307/2070346.
Pełny tekst źródłaBessa, Cláudia, Paulo Matos, Peter Jordan, and Vânia Gonçalves. "Alternative Splicing: Expanding the Landscape of Cancer Biomarkers and Therapeutics." International Journal of Molecular Sciences 21, no. 23 (2020): 9032. http://dx.doi.org/10.3390/ijms21239032.
Pełny tekst źródłaSong, Xiaowei, Zhenyu Zeng, Huanhuan Wei, and Zefeng Wang. "Alternative splicing in cancers: From aberrant regulation to new therapeutics." Seminars in Cell & Developmental Biology 75 (March 2018): 13–22. http://dx.doi.org/10.1016/j.semcdb.2017.09.018.
Pełny tekst źródłaCamino, Linda, and Kaja Finkler. "Spiritualist Healers in Mexico: Successes and Failures of Alternative Therapeutics." Journal of American Folklore 101, no. 399 (1988): 121. http://dx.doi.org/10.2307/540283.
Pełny tekst źródłaAlba, Annia, Carlos López-Abarrategui, and Anselmo J. Otero-González. "Host defense peptides: An alternative as antiinfective and immunomodulatory therapeutics." Biopolymers 98, no. 4 (2012): 251–67. http://dx.doi.org/10.1002/bip.22076.
Pełny tekst źródłaRuiz Reyes, Dionis, Maikro Osvaldo Chávez Moya, Ileana Beatriz Quiroga López, and Adriel Herrero Díaz. "Stem cells, regenerating medical therapeutics." Interdisciplinary Rehabilitation / Rehabilitacion Interdisciplinaria 6 (January 1, 2026): 181. https://doi.org/10.56294/ri2026181.
Pełny tekst źródłaQuazi, Mohzibudin Z., Jimin Hwang, Youngseo Song, and Nokyoung Park. "Hydrogel-Based Biosensors for Effective Therapeutics." Gels 9, no. 7 (2023): 545. http://dx.doi.org/10.3390/gels9070545.
Pełny tekst źródłaHazel, Karl, and Anthony O’Connor. "Emerging treatments for inflammatory bowel disease." Therapeutic Advances in Chronic Disease 11 (January 2020): 204062231989929. http://dx.doi.org/10.1177/2040622319899297.
Pełny tekst źródłaErnst, E. "The Washington Manual of Medical Therapeutics." Focus on Alternative and Complementary Therapies 7, no. 1 (2010): 68–69. http://dx.doi.org/10.1111/j.2042-7166.2002.tb03343.x.
Pełny tekst źródłaTogliatto, Gabriele, Patrizia Dentelli, and Maria Felice Brizzi. "Skewed Epigenetics: An Alternative Therapeutic Option for Diabetes Complications." Journal of Diabetes Research 2015 (2015): 1–7. http://dx.doi.org/10.1155/2015/373708.
Pełny tekst źródłaGupta, PD. "Menstrual Blood Mesenchymal Stem Cells: Boon in Therapeutics." Biotechnology and Bioprocessing 2, no. 4 (2021): 01–06. http://dx.doi.org/10.31579/2766-2314/032.
Pełny tekst źródłaImmadi Siva Ratnakar. "Phage Therapy: Challenges and Opportunities." Fine Focus 8, no. 1 (2022): 12–35. http://dx.doi.org/10.33043/ff.8.1.12-35.
Pełny tekst źródłaParvin, Nargish, Tapas K. Mandal, and Sang-Woo Joo. "The Impact of COVID-19 on RNA Therapeutics: A Surge in Lipid Nanoparticles and Alternative Delivery Systems." Pharmaceutics 16, no. 11 (2024): 1366. http://dx.doi.org/10.3390/pharmaceutics16111366.
Pełny tekst źródłaMukharji, Projit Bihari. "Dis-locating Subaltern Therapeutics." Asian Medicine 13, no. 1-2 (2018): 134–69. http://dx.doi.org/10.1163/15734218-12341411.
Pełny tekst źródłaTrucillo, Paolo. "Advances in Drug Delivery System Designs and Therapeutics." Processes 13, no. 4 (2025): 1176. https://doi.org/10.3390/pr13041176.
Pełny tekst źródłaVlaeminck, Jelle, Dina Raafat, Kristin Surmann, et al. "Exploring Virulence Factors and Alternative Therapies against Staphylococcus aureus Pneumonia." Toxins 12, no. 11 (2020): 721. http://dx.doi.org/10.3390/toxins12110721.
Pełny tekst źródłaMir, Rakeeb Ahmad, Anshika Tyagi, Sofi Javed Hussain, et al. "Saffron, a Potential Bridge between Nutrition and Disease Therapeutics: Global Health Challenges and Therapeutic Opportunities." Plants 13, no. 11 (2024): 1467. http://dx.doi.org/10.3390/plants13111467.
Pełny tekst źródłaPipe, Steven W. "Hemophilia: New Protein Therapeutics." Hematology 2010, no. 1 (2010): 203–9. http://dx.doi.org/10.1182/asheducation-2010.1.203.
Pełny tekst źródłaLu, Lunjie, Jun Zhou, Jingying Zhang, Jun Che, Yang Jiao, and Yusong Zhang. "Prevention and Therapeutic Effects and Mechanisms of Tanshinone IIA Sodium Sulfonate on Acute Liver Injury Mice Model." Evidence-Based Complementary and Alternative Medicine 2016 (2016): 1–8. http://dx.doi.org/10.1155/2016/4097398.
Pełny tekst źródłaStephens, Deborah M., and John C. Byrd. "How I manage ibrutinib intolerance and complications in patients with chronic lymphocytic leukemia." Blood 133, no. 12 (2019): 1298–307. http://dx.doi.org/10.1182/blood-2018-11-846808.
Pełny tekst źródłaSingh, Swati, and Matthew J. Smith. "RAS GTPase signalling to alternative effector pathways." Biochemical Society Transactions 48, no. 5 (2020): 2241–52. http://dx.doi.org/10.1042/bst20200506.
Pełny tekst źródłaRuigrok, Vincent J. B., Mark Levisson, Michel H. M. Eppink, Hauke Smidt, and John van der Oost. "Alternative affinity tools: more attractive than antibodies?" Biochemical Journal 436, no. 1 (2011): 1–13. http://dx.doi.org/10.1042/bj20101860.
Pełny tekst źródłaSchneider, Jay S. "GM1 Ganglioside as a Disease-Modifying Therapeutic for Parkinson’s Disease: A Multi-Functional Glycosphingolipid That Targets Multiple Parkinson’s Disease-Relevant Pathogenic Mechanisms." International Journal of Molecular Sciences 24, no. 11 (2023): 9183. http://dx.doi.org/10.3390/ijms24119183.
Pełny tekst źródłaMeir, Michal, and Daniel Barkan. "Alternative and Experimental Therapies of Mycobacterium abscessus Infections." International Journal of Molecular Sciences 21, no. 18 (2020): 6793. http://dx.doi.org/10.3390/ijms21186793.
Pełny tekst źródłaRuan, Ying-dan. "Summarization of constipation treated with Tuina therapeutics." Journal of Acupuncture and Tuina Science 6, no. 1 (2008): 62–64. http://dx.doi.org/10.1007/s11726-008-0062-8.
Pełny tekst źródłaOschman, James, and Lisa Tully. "Energy Medicine in Therapeutics and Human Performance." Journal of Alternative and Complementary Medicine 10, no. 2 (2004): 418. http://dx.doi.org/10.1089/107555304323062464.
Pełny tekst źródłaKotecha, Rupesh, Raees Tonse, Haley Appel, et al. "Regression of Intracranial Meningiomas Following Treatment with Cabozantinib." Current Oncology 28, no. 2 (2021): 1537–43. http://dx.doi.org/10.3390/curroncol28020145.
Pełny tekst źródłaUpadhyay, Harish C. "Medicinal Chemistry of Alternative Therapeutics: Novelty and Hopes with Genus Ammannia." Current Topics in Medicinal Chemistry 19, no. 10 (2019): 784–94. http://dx.doi.org/10.2174/1568026619666190412101047.
Pełny tekst źródłaJones, Jennifer, Craig P. Murphy, Roy D. Sleator, and Eamonn P. Culligan. "The urobiome, urinary tract infections, and the need for alternative therapeutics." Microbial Pathogenesis 161 (December 2021): 105295. http://dx.doi.org/10.1016/j.micpath.2021.105295.
Pełny tekst źródłaBougea, Anastasia, Christos Koros, Athina-Maria Simitsi, Chrysa Chrysovitsanou, Athanasios Leonardos, and Leonidas Stefanis. "Medical cannabis as an alternative therapeutics for Parkinsons’ disease: Systematic review." Complementary Therapies in Clinical Practice 39 (May 2020): 101154. http://dx.doi.org/10.1016/j.ctcp.2020.101154.
Pełny tekst źródłaLewis, Colin. "Book Review: Acupuncture Therapeutics." Acupuncture in Medicine 29, no. 2 (2011): 160. http://dx.doi.org/10.1136/acupmed-2011-010019.
Pełny tekst źródłaJenkins, Timothy, Thomas Fryer, Rasmus Dehli, et al. "Toxin Neutralization Using Alternative Binding Proteins." Toxins 11, no. 1 (2019): 53. http://dx.doi.org/10.3390/toxins11010053.
Pełny tekst źródła